ILLUMINATING CARDIAC RISKS, INSPIRING CONFIDENCE

See the blind spot before you stent.

During coronary bifurcation stenting, Side Branch Occlusion can accidentally block the artery — sometimes leading to severe heart attacks. Lumora predicts that risk for each patient, before the procedure begins.

Request a demo → Read the science
Golden light flowing into the vascular network of a human torso
THE BLIND CHALLENGE
As the stent deploys, the artery's own geometry can close the side branch — with no way to see it coming.
15–26%
of coronary bifurcation cases are affected by side branch occlusion.
€1–2k
saved per ICU night avoided when a severe SBO complication is prevented.
~1M
complex bifurcation procedures performed globally each year.
WHAT MAKES IT DIFFERENT

Generic risk scores don't help in a bifurcation. A number for this vessel does.

SCORE

A Quantified SBO Score

A proprietary algorithm, derived from biomechanical simulation, turns each patient's lesion and bifurcation geometry into a definitive numeric risk score and visual map.

vs. generic ischemia scoring (FFR-based tools)
LIVE

Built for the Cath Lab

Designed for real-time use inside the catheterization lab, so a strategy can be tested and chosen before deployment, not after.

vs. offline-only planning tools
THE PIPELINE

From standard images to a stenting decision, in three steps.

sbo-risk.onrender.com
Screen recording of the prototype on a synthetic phantom image — not patient data. Results are hidden: contact us for access.
EARLY PROTOTYPE

Try the first working version.

  • Opens DICOM angiograms
  • Traces the bifurcation automatically
  • Works on a phone or a workstation
Open the prototype →

Early version: the full clinical dataset is not connected yet, so results are preliminary. For research and demonstration only — not a medical device, not for clinical decisions.

The algorithm didn't start in a startup. It started in a lab.

From our published study: angiograms of four patients with coronary bifurcation stenosis, with the bifurcation angle (yellow, °) and vessel and lesion dimensions (white, mm) measured directly on the images. Bayatian et al., Physics of Fluids 37, 111909, Fig. 10 · doi.org/10.1063/5.0293854

Rooted in cardiovascular biomechanics

The core technology traces back through a Bachelor's in biomedical engineering, a Master's in the numerical modeling of endothelial cell motility, and a PhD studying endothelial cell behavior under pressure and velocity wave variation.

Peer-reviewed, not just proprietary

The team ran extensive simulations to identify the exact mechanical, biological, and geometric parameters that cause SBO — then published the core methodology in Physics of Fluids.

Where the technology is headed

Currently in the advanced simulation phase, building a generalized predictive model with early preliminary results. The long-term vision: a Lumora module built directly into hospital angiography platforms, such as those from Siemens Healthineers and Philips.

PUBLICATIONS

Peer-reviewed research behind the method.

TEAM

Clinical, technical, and commercial — in the room from day one.

Ahmad Nooraeen

Ahmad Nooraeen

Founder

PhD in Biomedical Engineering.

Leila Riahinezhad

Leila Riahinezhad

Co-founder

PhD in Marketing & Strategy, Biomedical Data Analyst.

AB

Ayat Bayatian

Consultant

Cardiologist & Interventionist.

CONTACT

Let's put a number on the risk no one could see before.

Cardiologists, hospitals, investors and industry partners — tell us a little about yourself and we'll get back to you.

Or write to us directly Lumora.cardiotech@gmail.com LinkedIn

We use your details only to reply to your message.